Loading…
MEMSIC Semiconductor completed a Series A funding round of over 1 billion yuan led by Shaoxing Yuexin Fund, with participation from a sovereign fund, Yunfeng Capital, and others. Proceeds will be used for production base construction and key technology R&D.
MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management (CRM) business of LivaNova for $190 million in cash.